Organiser:Weilian Exhibitions Time:August 8th – 9th, 2026 Address:East End of East University Street, Hohhot, Inner Mongolia Autonomous Region Exhibition hall: Inner Mongolia International Convention and Exhibition Center Product range: Pharmaceuticals, health supplements, medical supplies, medical devices, adult products, beauty and personal care products, home medical rehabilitation products, epidemic prevention materials, maternal and infant products, equipment and packaging About Inner Mongolia Pharmaceutical Fair: Inner Mongolia Pharmaceutical Fair & Inner Mongolia Medical Device Exhibition (referred to as “Inner Mongolia Pharmaceutical Fair”) is a well-known domestic trade fair for pharmaceuticals and health products. Founded in 1999, it is known as the “barometer of the national pharmaceutical and health product industry”, “China’s No.1 fixed-city pharmaceutical exhibition”, and has ranked as the largest fixed-city exhibition in China for ten consecutive years. As one of the oldest and largest branded industry events in China’s pharmaceutical sector, it covers all links of medical R&D, production, operation ...
Drugdu.com expert’s response: Under the EU MDR, the quality management system requirements for manufacturers are not limited to “production process compliance.” Manufacturers are expected to establish a quality management system that covers the full lifecycle of medical devices. In simple terms, the QMS should demonstrate that the product remains under continuous control from design and development, production and release, through to post-market feedback and risk control. The key requirements can be summarized in five areas: 1. Establish a quality management system that meets MDR requirements Manufacturers need to establish, implement, maintain and continuously improve their QMS. The system should cover processes such as product design and development, production, inspection, release, supplier management, document control, change control, nonconforming product handling, CAPA, internal audits and management review. 2. Include regulatory compliance in the QMS The QMS should clearly define product classification, conformity assessment routes, applicable standards, evidence of compliance with the General ...
Drugdu.com expert’s response: Medical devices are classified and managed into three categories in ascending order of risk level, with the Rules for the Classification of Medical Devices as the core basis. 1. Management Classification of Three Categories of Medical Devices Class I: Medical devices with low risk, whose safety and effectiveness can be ensured through routine management, such as ordinary medical surgical masks and medical examination gloves. Class II: Medical devices with moderate risk that require strict control and management to ensure safety and effectiveness, such as clinical thermometers and non-invasive monitors. Class III: Medical devices with relatively high risk that need particularly strict control measures to ensure safety and effectiveness, such as implantable cardiac pacemakers and artificial joints. 2. Supporting Classification Management Rules In addition to the risk classification of the products themselves, China also implements classified and hierarchical supervision for the production and operation links, clarifying the responsibilities of regulatory ...
Drugdu.com expert’s response: Recently, some suppliers have raised a very practical question: “My products already have views. Why are there still no buyer inquiries?” This is quite common for medical device products. When medical device buyers browse products on a platform, they usually do not send an inquiry immediately after seeing one product. They first make a judgment: Is this the product I am looking for? Is this company reliable? Can the certificates and documents support my target market? Will communication with this supplier be complicated? So, having views does not mean inquiries will come right away. Views show that the product has received a certain level of exposure. But whether buyers are willing to make further contact depends on whether the product page and company information can support their sourcing decision. 1. Buyers saw the product, but did not see a clear reason to contact you For many product ...
Originally produced by Yang Xixia, Jianshi Bureau, July 14, 2026 20:24 Beijing On July 14, China’s innovative drug industry saw another major deal: ج Dizal Pharma willgrant AstraZeneca the exclusive global development and commercialization rights to suvolotinib. AstraZeneca will pay Dizal Pharma a $600 million upfront payment and $900 million in milestone payments, with clinical development and sales milestones capped at $400 million and $500 million, respectively. Simply put, AstraZenecabought out suvolotinib outright for $1.5 billion. As soon as the news broke, Dizal Pharma’s stock surged 20CM in the afternoon. The capital market recognized the certainty of this deal. Unlike other BD deals that often run into the billions of dollars, Dizhe’s $1.5 billion total may not be large, but the $600 million upfront payment is real cash in hand, and the future milestone payments are also highly certain. This is the fundamental reason the market is willing to pay ...
Organiser:Medical Association of Bogotá Chamber of Commerce, Messe Düsseldorf GmbH Time:July 28th – July 31st, 2026 Address:CORFERIAS Bogotá – Colombia Todos los derechos reservados, Carrera 37 No 24 – 67 Conmutador Exhibition hall:Corferias Bogota Product range: Medical Instruments and Equipment: Surgical instruments, surgical orthopedic supplies, orthopedic products, diagnostic equipment, monitoring equipment, therapeutic equipment, disinfection and sterilization equipment, preventive medical equipment, ophthalmic instruments and equipment, otolaryngological equipment, radiological medical equipment, rehabilitation physiotherapy equipment, traction and correction equipment, prosthetics and rehabilitation devices, medical vehicles, beds and tables, first-aid and ambulance equipment, medical auxiliary equipment, etc. Medical Institutions and Laboratory Technical Equipment: Laboratory instruments and equipment, laboratory furniture, laboratory automation and accessories, optical instruments and equipment, medical experimental analysis and diagnostic instruments, biotechnology equipment, etc. Medical Materials: Disposable medical consumables, surgical hygiene products, dressings, wound care materials, catheters, interventional materials, first-aid kits, first-aid packs, other medical materials, etc. Healthcare Products: Medical electronic ...
Drugdu.com expert’s response: Medical devices are a highly regulated product category worldwide. In foreign trade communication, customs clearance, and overseas regulatory inspections, many vaguely expressed, inconsistent, or unsupported details can easily lead to repeated inquiries from buyers, cargo detention, and order delays. Many suppliers only briefly inform customers that “all certificates are complete and compliant” without sorting out industry-specific controversial points in advance, resulting in repetitive and inefficient communication.I. Qualification Certificates: Complete in Name but Mismatched in Details (Most Frequently Questioned) This is the most frequently questioned area by customers. Many companies only generally claim to have “a full set of certificates,” yet suffer from inconsistent information, ambiguous scope of application, and unclear validity periods. Domestic Qualification Matching Common ambiguities: Whether the model, production address, and product scope on the Class I/II/III medical device registration/filing certificate, production license, and export sales certificate are fully consistent; whether a compliant export ...
Drugdu.com expert’s response: In daily sales and procurement communication, many suppliers share a common confusion: even after clearly telling buyers that “all certificates are complete and qualifications are formal,” the other party still keeps asking questions and repeatedly requests various supporting documents. Many people assume that the buyer is distrustful or deliberately being difficult, but this is not the case. Such behavior is not personal; it is an inevitable result of risk control, compliance requirements, process standards, and trust-building in the procurement process, with very practical and reasonable underlying logic. First and foremost, the buyer’s core concern is the authenticity and validity of the certificates. The current market environment is complex, and cases of forged certificates, misappropriated certificates, expired qualifications, and use beyond authorized scope are not uncommon. Especially in highly regulated industries such as pharmaceuticals, chemicals, food, building materials, and import/export, one non-compliant qualification can lead to seizure of ...
Company Profile We are a high-tech enterprise oriented towards research and development, specializing in the fields of pharmaceutical raw materials, intermediates, peptide components, cosmetic raw materials, and nutritional supplement raw materials. We offer standardized large-scale production services and conduct global wholesale business. Our multiple peptide raw materials possess core physiological effects such as weight loss, muscle building, blood sugar reduction, and anti-aging, are widely applicable to the research and production demands in the pharmaceutical, beauty, and health care sectors. We adopt strict batch production standards and have sufficient production capacity and stable supply capabilities. All products have been professionally tested by third-party institutions and come with complete test reports and qualification certificates, ensuring stable batch quality and complete traceability. For large-scale orders, we offer competitive wholesale prices. We uphold the core values of integrity, pragmatism, innovation and development, and continuously enhance our technical strength and product quality. Product Introduction We ...
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.